Analyst Price Targets — SENS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 11:26 am | Anthony Petrone | Mizuho Securities | $18.00 | $5.03 | TheFly | Senseonics price target lowered to $18 from $20 at Mizuho |
| May 12, 2026 10:06 am | — | H.C. Wainwright | $14.00 | $5.77 | TheFly | Senseonics price target lowered to $14 from $18.50 at H.C. Wainwright |
| May 11, 2026 11:40 am | Jonathan Block | Stifel Nicolaus | $8.00 | $5.03 | TheFly | Senseonics price target lowered to $8 from $9 at Stifel |
| March 3, 2026 2:33 pm | Jonathan Block | Stifel Nicolaus | $9.00 | $7.21 | StreetInsider | Stifel Reiterates Hold Rating on Senseonics Holdings (SENS) |
| June 2, 2025 10:11 am | Sean Lee | H.C. Wainwright | $22.00 | $10.60 | TheFly | Senseonics assumed with a Buy at H.C. Wainwright |
| July 25, 2022 6:26 am | — | H.C. Wainwright | $60.00 | $25.80 | Benzinga | HC Wainwright & Co. Maintains Buy on Senseonics Holdings, Lowers Price Target to $3 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for SENS

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM's differentiated approach and high performance

Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript

GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today highlights two key company events during the 86th Scientific Sessions of the American Diabetes Association (ADA), taking place June…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SENS.
U.S. House Trading
No House trades found for SENS.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
